324 filings
Page 5 of 17
8-K
nps3bn
29 Sep 20
PolarityTE Announces Termination of Shareholder Rights Plan
8:00am
8-K
ic2nchm0aknq2m
23 Sep 20
Other Events
8:00am
8-K
52itei9cy4s1t4
16 Sep 20
SkinTE™ Health Economics—DFU Interim Analysis Data Demonstrates Potential for Cost Savings and Improved Wound Closure
8:00am
8-K
058fk25zgq0r
14 Sep 20
Regulation FD Disclosure
8:00am
8-K
h15jzxvhr ptf
8 Sep 20
PolarityTE Announces Strategic Partnership with Co-Diagnostics to Expand COVID-19 Testing Platform
8:30am
8-K
khrrdm6c
6 Aug 20
PolarityTE Reports Second Quarter 2020 Results
7:00am
8-K
3vd6m09hwe x7
30 Jul 20
PolarityTE Announces the Addition of Clinical Development and Regulatory Affairs Executive Jessica Shen, MD, MS to Board of Directors
8:00am
8-K
4d26l7n9s04c1 gck3
27 Jul 20
Regulation FD Disclosure
4:30pm
8-K
7he8oyifvbo7 fb
24 Jul 20
PolarityTE Announces Positive Top-Line Data from Interim Analysis of SkinTE™ Diabetic Foot Ulcer Trial
8:00am
8-K
vcb9x5f3 d4b6
22 May 20
Other Events
4:05pm
8-K
19uyiaih2w mcrq55pua
30 Apr 20
PolarityTE Provides Update on Corporate Strategy and Regulatory Pathway for SkinTE
4:15pm
8-K
qtd yfm911mu3
21 Apr 20
PolarityTE Provides Corporate Update Related to COVID-19 and Announces Preliminary First Quarter Results
8:00am
8-K
rxkan
15 Apr 20
Entry into a Material Definitive Agreement
8:00am
8-K
3mtpala r97t
8 Apr 20
Other Events
8:30am
8-K
9dn qyays3ad44fok
7 Apr 20
PolarityTE Announces the Addition of Audit Executive Chris Nolet to Board of Directors
8:00am
8-K
26658 ixkoi
1 Apr 20
PolarityTE Announces Appointment of David Seaburg as CEO and Restructuring of Executive Team
8:30am
8-K
1tzooi55u
27 Mar 20
Regulation FD Disclosure
8:00am
8-K
szjx0oplf
25 Mar 20
Entry into a Material Definitive Agreement
8:17am
8-K
we24083urdcn afbv
12 Mar 20
PolarityTE Reports Fiscal Year 2019 Financial Results
8:00am
8-K
izl btl2ugpw
14 Feb 20
PolarityTE Announces Public Offering of Common Stock and Warrants
6:05am